Skip to main content
. 2023 Oct 12;11(10):2770. doi: 10.3390/biomedicines11102770

Figure 2.

Figure 2

(a,b) Inflammatory analytes comparing the odds ratios of low/medium vs. highest percent of sites with PPD ≥ 4 mm or CAL ≥ 4 mm for serum and GCF.